Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: Fierce 15 nominations are now open! We're looking for the best and brightest in biotech.
Licensing deals
Biotech
Erasca lays off 18%, swaps out KRAS program for fresh options
Erasca is spending $22.5 million to import fresh KRAS and molecular glue assets while clearing space in its pipeline and laying off 18% of staff.
James Waldron
May 17, 2024 5:30am
AbbVie pens $2B-plus neuro pact with Gilgamesh
May 13, 2024 5:57pm
Takeda pays AC Immune $100M upfront for a ph. 2 Alzheimer's drug
May 13, 2024 5:51am
After FTC stalled Sanofi deal, Shionogi bags Maze's Pompe drug
May 10, 2024 5:02am
Pharming uproots angioedema gene therapy collab with Orchard
May 8, 2024 6:15am
Moderna exits Metagenomi gene editing deal worth $3B biobucks
May 1, 2024 4:00pm